Sun BioPharma, Inc. (44)
Browse by Contract Category
Contracts
-
Form of Common Stock Purchase Warrant
(Filed With SEC on January 23, 2023)
-
Form of Placement Agency Agreement
(Filed With SEC on January 18, 2023)
-
License Agreement, dated June 16, 2021 between Cancer Prevention Pharmaceuticals, Inc. and One-Two Therapeutic Assets Limited
(Filed With SEC on August 15, 2022)
-
Dr. Suzanne Gagnon Consulting Agreement
(Filed With SEC on March 24, 2022)
-
Agreement and Plan of Merger, dated February21, 2022, by and among Panbela Therapeutics, Inc., Canary Merger Holdings, Inc., Canary Merger Subsidiary I, Inc., Canary Merger...
(Filed With SEC on February 22, 2022)
-
Description of Securities
(Filed With SEC on March 25, 2021)
-
Form of Warrant Agency Agreement
(Filed With SEC on January 23, 2023)
-
Form of Securities Purchase Agreement
(Filed With SEC on January 18, 2023)
-
Form of Pre-Funded Warrant
(Filed With SEC on January 18, 2023)
-
Form of Common Stock Purchase Warrant
(Filed With SEC on January 18, 2023)
-
Form of Warrant Agency Agreement
(Filed With SEC on January 18, 2023)
-
Form of Pre-Funded Common Stock Purchase Warrant
(Filed With SEC on October 4, 2022)
-
Warrant Agency Agreement dated as of October 4, 2022 by and between Panbela Therapeutics, Inc. and VStock Transfer, LLC
(Filed With SEC on October 4, 2022)
-
Form of Common Stock Purchase Warrant
(Filed With SEC on October 4, 2022)
-
Placement Agency Agreement dated as of September 29, 2022 by and between Panbela Therapeutics, Inc. and Roth Capital Partners, LLC
(Filed With SEC on October 4, 2022)
-
Form of Securities Purchase Agreement by and between Panbela Therapeutics, Inc. and the purchasers named therein
(Filed With SEC on October 4, 2022)
-
Form of Placement Agency Agreement
(Filed With SEC on September 6, 2022)
-
Form of Securities Purchase Agreement
(Filed With SEC on September 6, 2022)
-
Form of Warrant Agency Agreement
(Filed With SEC on September 6, 2022)
-
Form of Pre-Funded Warrant
(Filed With SEC on September 6, 2022)
-
Form of Common Stock Purchase Warrant
(Filed With SEC on September 6, 2022)
-
Sales Agreement, dated July 19, 2022 with Roth Capital Partners, LLC
(Filed With SEC on July 20, 2022)
-
Amended and Restated Underwriting Agreement, dated June 29, 2021, by and between Panbela Therapeutics, Inc. and H.C. Wainwright & Co., LLC
(Filed With SEC on July 2, 2021)
-
Warrant Agency Agreement with VStock Transfer, LLC dated September 1, 2020
(Filed With SEC on September 1, 2020)
-
Underwriting Agreement dated August 28, 2020
(Filed With SEC on September 1, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on August 27, 2020)
-
Form of Warrant Agency Agreement
(Filed With SEC on August 20, 2020)
-
Form of Underwriter Common Stock Purchase Warrant
(Filed With SEC on August 20, 2020)
-
Form of Common Stock Purchase Warrant
(Filed With SEC on August 20, 2020)
-
Form of Underwriting Agreement
(Filed With SEC on August 20, 2020)
-
Form of Employee Confidentiality and Intellectual Property Assignment Agreement with Company Officers
(Filed With SEC on August 11, 2020)
-
Employment Agreement with Jennifer K. Simpson, effective July 15, 2020
(Filed With SEC on July 16, 2020)
-
Form of Securities Purchase Agreement
(Filed With SEC on June 11, 2020)
-
Form of Warrant
(Filed With SEC on June 11, 2020)
-
Third Amendment to Seed Capital Accelerator Loan Agreement and Seed Capital Loan Noted dated December 31,2019
(Filed With SEC on March 24, 2020)
-
Seed Capital Accelerator Loan Agreement and Seed Capital Loan Note dated October 26, 2012
(Filed With SEC on March 24, 2020)
-
Form of First Amendment to License Agreement with University of Florida Research Foundation, Inc. dated December 12, 2016
(Filed With SEC on March 24, 2020)
-
Description of Securities
(Filed With SEC on March 24, 2020)
-
Second Amendment to License Agreement No. A9672 between Sun BioPharma, Inc. and University of Florida Research Foundation, Inc., dated as of October 3, 2019
(Filed With SEC on October 9, 2019)
-
Form of Securities Purchase Agreement
(Filed With SEC on August 29, 2019)
-
Form of Warrant
(Filed With SEC on August 29, 2019)
-
Second Amendment to Seed Capital Accelerator Loan Agreement and Seed Capital Loan Note dated April 5, 2019
(Filed With SEC on May 14, 2019)
-
Form of Warrant issued April 2, 2019
(Filed With SEC on May 14, 2019)
-
Amendment to Seed Capital Accelerator Loan Agreement and Seed Capital Loan Note dated October 13, 2017
(Filed With SEC on May 14, 2019)
